Oncology & Cancer

A novel strategy to suppress triple negative breast cancer growth

In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies. Looking ...

Oncology & Cancer

Uncovering why some cells become resistant to anti-cancer therapies

A research team led by Northwestern University and the University of Pennsylvania scientists has created a new synthetic biology approach, a "QR code for cancer cells," to follow tumor cells over time, finding there are meaningful ...

page 8 from 40